162 related articles for article (PubMed ID: 9468544)
1. The role of annexin II tetramer in the activation of plasminogen.
Kassam G; Choi KS; Ghuman J; Kang HM; Fitzpatrick SL; Zackson T; Zackson S; Toba M; Shinomiya A; Waisman DM
J Biol Chem; 1998 Feb; 273(8):4790-9. PubMed ID: 9468544
[TBL] [Abstract][Full Text] [Related]
2. The p11 subunit of the annexin II tetramer plays a key role in the stimulation of t-PA-dependent plasminogen activation.
Kassam G; Le BH; Choi KS; Kang HM; Fitzpatrick SL; Louie P; Waisman DM
Biochemistry; 1998 Dec; 37(48):16958-66. PubMed ID: 9836589
[TBL] [Abstract][Full Text] [Related]
3. Regulation of plasmin activity by annexin II tetramer.
Fitzpatrick SL; Kassam G; Choi KS; Kang HM; Fogg DK; Waisman DM
Biochemistry; 2000 Feb; 39(5):1021-8. PubMed ID: 10653646
[TBL] [Abstract][Full Text] [Related]
4. Phospholipid-associated annexin A2-S100A10 heterotetramer and its subunits: characterization of the interaction with tissue plasminogen activator, plasminogen, and plasmin.
MacLeod TJ; Kwon M; Filipenko NR; Waisman DM
J Biol Chem; 2003 Jul; 278(28):25577-84. PubMed ID: 12730231
[TBL] [Abstract][Full Text] [Related]
5. Role of annexin II tetramer in plasminogen activation.
Kang HM; Choi KS; Kassam G; Fitzpatrick SL; Kwon M; Waisman DM
Trends Cardiovasc Med; 1999; 9(3-4):92-102. PubMed ID: 10578524
[TBL] [Abstract][Full Text] [Related]
6. An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation.
Cesarman GM; Guevara CA; Hajjar KA
J Biol Chem; 1994 Aug; 269(33):21198-203. PubMed ID: 8063741
[TBL] [Abstract][Full Text] [Related]
7. Annexin II tetramer inhibits plasmin-dependent fibrinolysis.
Choi KS; Ghuman J; Kassam G; Kang HM; Fitzpatrick SL; Waisman DM
Biochemistry; 1998 Jan; 37(2):648-55. PubMed ID: 9425087
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the heparin binding properties of annexin II tetramer.
Kassam G; Manro A; Braat CE; Louie P; Fitzpatrick SL; Waisman DM
J Biol Chem; 1997 Jun; 272(24):15093-100. PubMed ID: 9182528
[TBL] [Abstract][Full Text] [Related]
9. Conversion of Glu-plasminogen to Lys-plasminogen is necessary for optimal stimulation of plasminogen activation on the endothelial cell surface.
Gong Y; Kim SO; Felez J; Grella DK; Castellino FJ; Miles LA
J Biol Chem; 2001 Jun; 276(22):19078-83. PubMed ID: 11264290
[TBL] [Abstract][Full Text] [Related]
10. Annexin A2-S100A10 heterotetramer, a novel substrate of thioredoxin.
Kwon M; Yoon CS; Jeong W; Rhee SG; Waisman DM
J Biol Chem; 2005 Jun; 280(25):23584-92. PubMed ID: 15849182
[TBL] [Abstract][Full Text] [Related]
11. The p11 subunit of annexin II heterotetramer is regulated by basic carboxypeptidase.
Fogg DK; Bridges DE; Cheung KK; Kassam G; Filipenko NR; Choi KS; Fitzpatrick SL; Nesheim M; Waisman DM
Biochemistry; 2002 Apr; 41(15):4953-61. PubMed ID: 11939791
[TBL] [Abstract][Full Text] [Related]
12. S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors.
Kwon M; MacLeod TJ; Zhang Y; Waisman DM
Front Biosci; 2005 Jan; 10():300-25. PubMed ID: 15574370
[TBL] [Abstract][Full Text] [Related]
13. The role of the annexin A2 heterotetramer in vascular fibrinolysis.
Madureira PA; Surette AP; Phipps KD; Taboski MA; Miller VA; Waisman DM
Blood; 2011 Nov; 118(18):4789-97. PubMed ID: 21908427
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine phosphorylation of annexin II tetramer is stimulated by membrane binding.
Bellagamba C; Hubaishy I; Bjorge JD; Fitzpatrick SL; Fujita DJ; Waisman DM
J Biol Chem; 1997 Feb; 272(6):3195-9. PubMed ID: 9013554
[TBL] [Abstract][Full Text] [Related]
15. Ethanol-induced increased surface-localized fibrinolytic activity in cultured human endothelial cells: kinetic analysis.
Abou-Agag LH; Tabengwa EM; Tresnak JA; Wheeler CG; Taylor KB; Booyse FM
Alcohol Clin Exp Res; 2001 Mar; 25(3):351-61. PubMed ID: 11290845
[TBL] [Abstract][Full Text] [Related]
16. Annexin II: a mediator of the plasmin/plasminogen activator system.
Hajjar KA; Krishnan S
Trends Cardiovasc Med; 1999 Jul; 9(5):128-38. PubMed ID: 10639727
[TBL] [Abstract][Full Text] [Related]
17. Identification of annexin II heterotetramer as a plasmin reductase.
Kwon M; Caplan JF; Filipenko NR; Choi KS; Fitzpatrick SL; Zhang L; Waisman DM
J Biol Chem; 2002 Mar; 277(13):10903-11. PubMed ID: 11781322
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor type 2 inhibits cell surface associated tissue plasminogen activator in vitro: potential receptor interactions.
Lobov S; Croucher DR; Saunders DN; Ranson M
Thromb Haemost; 2008 Aug; 100(2):319-29. PubMed ID: 18690354
[TBL] [Abstract][Full Text] [Related]
19. Modulation of annexin II tetramer by tyrosine phosphorylation.
Hubaishy I; Jones PG; Bjorge J; Bellagamba C; Fitzpatrick S; Fujita DJ; Waisman DM
Biochemistry; 1995 Nov; 34(44):14527-34. PubMed ID: 7578058
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the Ca2+-binding sites of annexin II tetramer.
Filipenko NR; Kang HM; Waisman DM
J Biol Chem; 2000 Dec; 275(49):38877-84. PubMed ID: 10980196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
